Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting T cells for asthma.

Irene H Heijink1, Antoon J M Van Oosterhout

  • 1Laboratory of Allergology and Pulmonary Diseases and Department of Pathology, University Medical Center Groningen (UMCG), Groningen University, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands.

Current Opinion in Pharmacology
|May 24, 2005
PubMed
Summary

Targeting type 2 T-helper (Th2) lymphocytes is key for allergic asthma treatment. Strategies focus on inhibiting Th2 cell migration and activation, with new therapies exploring counter-regulatory immune cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohort.

EBioMedicine·2026
Same author

Protocadherin-1 deficiency increases baseline and allergen-induced airway hyperresponsiveness in mice.

American journal of respiratory cell and molecular biology·2026
Same author

A comprehensive multi-omics and functional study of evolutionary adaptive responses to smoke.

iScience·2026
Same author

Fibroblast cross talk promotes mucin synthesis by COPD-derived airway epithelial cells.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Accessible Silicone Chip-to-Membrane Sealing Procedure for Flexible, Reliable Bonding.

Journal of visualized experiments : JoVE·2026
Same author

Regenerative therapeutics for chronic obstructive pulmonary disease.

Pharmacological reviews·2026

Area of Science:

  • Immunology
  • Allergology
  • Pharmacology

Background:

  • Type 2 T-helper (Th2) lymphocytes are central to allergic asthma pathogenesis.
  • Th2 cells drive disease initiation, progression, and persistence.

Purpose of the Study:

  • To explore therapeutic strategies targeting Th2 lymphocytes for allergic asthma.
  • To review current and emerging drug development approaches.

Main Methods:

  • Review of drug targets including chemokine receptors (CCR4) and adhesion molecules (VLA-4).
  • Investigation of novel inhibitors targeting Th2-selective transcription factors like GATA3.
  • Exploration of counter-regulatory immune cell generation (Th1 and regulatory T cells).

Main Results:

Related Experiment Videos

  • Drugs preventing Th2 cell migration (anti-CCR4, anti-VLA-4) show promise.
  • Development of novel drugs targeting Th2 activation pathways is ongoing.
  • Counter-regulatory immune responses are a new therapeutic avenue.

Conclusions:

  • Th2 lymphocytes are a critical therapeutic target for allergic asthma.
  • Multiple strategies, including migration inhibition, activation blocking, and immune modulation, are being developed.